Product Information
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $1.3412 per EA under NDC 33342024610. Its NADAC has been published 28 times since Dec 17, 2025.
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5
Olmesartan medoxomil Amlodipine and HydrochlorothiazideStrength
10; 12.5; 40 mg/1; mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342024610
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207088On Market Since
7/18/2025
Pharmacological Classes
Price Statistics
The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 3.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3412 per EA |
|---|---|
| All-time high | $1.4139 (Jun 10, 2026) |
| All-time low | $1.2566 (Mar 18, 2026) |
| 52-week high | $1.4139 |
| 52-week low | $1.2566 |
| Median price | $1.3751 |
| Average price | $1.3489 |
| Largest weekly change | +9.4% (Apr 22, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, manufactured by Macleods Pharmaceuticals Limited, is $1.3412 per EA (NDC 33342024610), effective Jun 24, 2026.
How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 changed over time?
Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has declined 3.1%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
Since Dec 17, 2025, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has ranged from a low of $1.2566 (Mar 18, 2026) to a high of $1.4139 (Jun 10, 2026), with a median of $1.3751 per EA.
Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, but none are currently priced below it.
Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 (NDC 33342024610) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification